ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Marushika Technology Limited held its 16th Annual General Meeting on September 25, 2026. The meeting covered the adoption of financial statements and various board appointments.
Marushika Technology commenced a partnership with Sanare Medical as exclusive distributor of ExoAtlet II. The agreement targets government procurement via GeM across Indian public institutions.
Marushika Technology Limited has shifted its registered office to a new location in New Delhi, effective September 14, 2026.
Marushika Technology dispatched physical letters to shareholders providing the weblink to access the Annual Report and Notice of the 16th Annual General Meeting. This complies with regulatory requirements.
Marushika Technology Limited will hold its 16th Annual General Meeting on September 25, 2026. The agenda includes financial statement adoption and director appointments.
Marushika Technology Limited concluded FY26 reporting 36.6% revenue growth and 42.5% PAT growth post-IPO. Strategy focuses on high-margin services, data centers, and defense auto tech.
Marushika Technology Limited reports a strong FY26, beating internal projections through aggressive execution in high-margin sectors like data centers and defense autotech.
Marushika Technology Limited reported strong FY26 performance with 36.6% revenue growth and 42.5% PAT growth, driven by IT infrastructure and defense auto-tech expansion.
Marushika Technology Ltd reported revenue from operations of ₹67.8 Cr and net profit of ₹5.8 Cr for H2 FY26.